
Personalized regenerative medicines, Nabiha Saklayen, PhD, Co-Founder & CEO, Cellino
Biotech 2050 Podcast
00:00
How Are You Thinking About the Next Fundraising Cycle?
The biotech sector is in the midst of a correction. How are you thinking about the changing dynamic now? And if you're making any changes in terms of where you spend capital or how you're approaching the next fundraising cycle.? I'm watching a lot of my fellow CEOs actually across the board, first-time founders or serial CEOs that have done this 10 times. Everybody is in a different and much harder situation this year. It's tough to see companies that are doing exceptionally well but not being able to raise money because markets aren't working for them.
Play episode from 24:14
Transcript


